These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22105646)

  • 1. Immunotoxicant screening and prioritization in the twenty-first century.
    Luebke R
    Toxicol Pathol; 2012; 40(2):294-9. PubMed ID: 22105646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Present and future of in vitro immunotoxicology in drug development.
    Galbiati V; Mitjans M; Corsini E
    J Immunotoxicol; 2010; 7(4):255-67. PubMed ID: 20735150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro testing for direct immunotoxicity: state of the art.
    Lankveld DP; Van Loveren H; Baken KA; Vandebriel RJ
    Methods Mol Biol; 2010; 598():401-23. PubMed ID: 19967527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of drug-induced toxic effects on the immune system as assessed by proliferative assays and cytokine production.
    Pallardy M; Lebrec H; Blot C; Burleson GR; Bohuon C
    Eur Cytokine Netw; 1991; 2(3):201-6. PubMed ID: 1893072
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotoxicity of pesticides: perspectives and trends.
    Banerjee BD; Koner BC; Ray A
    Indian J Exp Biol; 1996 Aug; 34(8):723-33. PubMed ID: 8979476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule immunomodulatory drugs: challenges and approaches for balancing efficacy with toxicity.
    Haley PJ
    Toxicol Pathol; 2012; 40(2):261-6. PubMed ID: 22083586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The accuracy of extended histopathology to detect immunotoxic chemicals.
    Germolec DR; Kashon M; Nyska A; Kuper CF; Portier C; Kommineni C; Johnson KA; Luster MI
    Toxicol Sci; 2004 Dec; 82(2):504-14. PubMed ID: 15342959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are pesticides immunotoxic?
    Botham PA
    Adverse Drug React Acute Poisoning Rev; 1990; 9(2):91-101. PubMed ID: 2220474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential future requirements for immunotoxicology testing of pesticides.
    Sjoblad RD
    Toxicol Ind Health; 1988 Sep; 4(3):391-5. PubMed ID: 3176044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing human biologicals in animal host resistance models.
    Burleson GR; Burleson FG
    J Immunotoxicol; 2008 Jan; 5(1):23-31. PubMed ID: 18382855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FIFRA Subdivision F testing Guidelines: are these tests adequate to detect potential hormonal activity for crop protection chemicals? Federal Insecticide, Fungicide, and Rodenticide Act.
    Stevens JT; Tobia A; Lamb JC; Tellone C; O'Neal F
    J Toxicol Environ Health; 1997 Apr; 50(5):415-31. PubMed ID: 9140462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory immunotoxicology: does the published evidence support mandatory nonclinical immune function screening in drug development?
    Snodin DJ
    Regul Toxicol Pharmacol; 2004 Dec; 40(3):336-55. PubMed ID: 15546688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory forum opinion piece*: immunotoxicology assessments in nonhuman primates--challenges and opportunities.
    Lebrec HN
    Toxicol Pathol; 2013; 41(3):548-51. PubMed ID: 22886347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of xenobiotics for direct immunotoxicity in an animal study.
    De Jong WH; Van Loveren H
    Methods; 2007 Jan; 41(1):3-8. PubMed ID: 17161297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended histopathology in immunotoxicity testing: interlaboratory validation studies.
    Germolec DR; Nyska A; Kashon M; Kuper CF; Portier C; Kommineni C; Johnson KA; Luster MI
    Toxicol Sci; 2004 Mar; 78(1):107-15. PubMed ID: 14691208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune modulator studies in primates: the utility of flow cytometry and immunohistochemistry in the identification and characterization of immunotoxicity.
    Lappin PB; Black LE
    Toxicol Pathol; 2003; 31 Suppl():111-8. PubMed ID: 12597438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza virus host resistance model.
    Burleson GR; Burleson FG
    Methods; 2007 Jan; 41(1):31-7. PubMed ID: 17161300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodologies for developmental immunotoxicity (DIT) testing.
    Dietert RR; Holsapple MP
    Methods; 2007 Jan; 41(1):123-31. PubMed ID: 17161309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of regulatory T-cell function by immunomodulators: a boon or a curse?
    Fort MM; Narayanan PK
    Toxicol Sci; 2010 Oct; 117(2):253-62. PubMed ID: 20484381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.